Immediate Impact
1 from Science/Nature 60 standout
Citing Papers
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Guo‐He Lin being referenced
Durvalumab and tremelimumab combination therapy versus durvalumab or tremelimumab monotherapy for patients with solid tumors
2020
Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Guo‐He Lin | 260 | 70 | 104 | 115 | 37 | 413 | |
| Kartik Viswanathan | 177 | 79 | 135 | 107 | 28 | 405 | |
| Yu Fujiwara | 280 | 98 | 64 | 90 | 53 | 481 | |
| Jolanta Szelachowska | 245 | 61 | 60 | 205 | 34 | 504 | |
| I Ruschenburg | 186 | 66 | 88 | 186 | 41 | 457 | |
| Mariachiara Santorsola | 199 | 85 | 77 | 114 | 43 | 381 | |
| Manali Rupji | 159 | 102 | 60 | 178 | 44 | 453 | |
| Shigenori Furukawa | 134 | 55 | 59 | 155 | 41 | 411 | |
| Tianyi Fang | 230 | 162 | 110 | 110 | 36 | 439 | |
| Yiming Mao | 138 | 227 | 91 | 112 | 39 | 445 | |
| Chuang Qi | 292 | 161 | 56 | 136 | 36 | 475 |
All Works
Loading papers...